2017 Q2 Form 10-Q Financial Statement

#000146310117000054 Filed on May 10, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2017 Q1 2016 Q1
Revenue $74.70M $54.75M $64.12M
YoY Change -5.66% -14.61% -26.0%
Cost Of Revenue $61.16M $47.70M $52.36M
YoY Change -5.98% -8.9% -10.69%
Gross Profit $13.55M $7.048M $11.76M
YoY Change -4.17% -40.07% -58.04%
Gross Profit Margin 18.13% 12.87% 18.34%
Selling, General & Admin $11.24M $12.29M $17.78M
YoY Change -33.24% -30.88% -11.72%
% of Gross Profit 82.96% 174.39% 151.21%
Research & Development $7.947M $9.605M $13.07M
YoY Change -39.29% -26.49% -2.71%
% of Gross Profit 58.66% 136.28% 111.11%
Depreciation & Amortization $2.300M $2.328M $2.680M
YoY Change -14.81% -13.13% 5.85%
% of Gross Profit 16.98% 33.03% 22.79%
Operating Expenses $22.79M $29.14M $30.85M
YoY Change -23.83% -5.53% -8.11%
Operating Profit -$9.247M -$22.10M -$19.09M
YoY Change -41.43% 15.75% 244.05%
Interest Expense $2.080M $2.139M $152.0K
YoY Change 881.13% 1307.24% 94.87%
% of Operating Profit
Other Income/Expense, Net -$1.992M -$1.079M $529.0K
YoY Change 237.06% -303.97% -187.44%
Pretax Income -$11.24M -$23.17M -$18.56M
YoY Change -31.38% 24.87% 201.63%
Income Tax $854.0K $131.0K $236.0K
% Of Pretax Income
Net Earnings -$12.09M -$23.31M -$18.80M
YoY Change -27.69% 24.0% 197.39%
Net Earnings / Revenue -16.19% -42.57% -29.31%
Basic Earnings Per Share
Diluted Earnings Per Share -$143.4K -$303.8K -$406.9K
COMMON SHARES
Basic Shares Outstanding 84.28M shares 82.53M shares 46.21M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.00M $30.00M $13.00M
YoY Change 278.05% 130.77% -52.03%
Cash & Equivalents $30.95M $29.96M $13.02M
Short-Term Investments
Other Short-Term Assets $13.30M $10.10M $7.200M
YoY Change 68.35% 40.28% 1.41%
Inventory $20.84M $33.81M $45.58M
Prepaid Expenses
Receivables $56.40M $48.90M $47.06M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $121.5M $122.8M $112.9M
YoY Change 16.34% 8.78% -1.69%
LONG-TERM ASSETS
Property, Plant & Equipment $29.35M $30.91M $32.96M
YoY Change -15.15% -6.24% 5.66%
Goodwill $3.664M $3.664M $3.745M
YoY Change -2.16% -2.16% 0.0%
Intangibles $668.0K $806.0K $2.036M
YoY Change -63.93% -60.41% 19.48%
Long-Term Investments
YoY Change
Other Assets $8.493M $9.333M $6.891M
YoY Change 7.71% 35.44% 242.15%
Total Long-Term Assets $42.18M $44.71M $45.64M
YoY Change -12.27% -2.03% 18.04%
TOTAL ASSETS
Total Short-Term Assets $121.5M $122.8M $112.9M
Total Long-Term Assets $42.18M $44.71M $45.64M
Total Assets $163.7M $167.5M $158.5M
YoY Change 7.32% 5.67% 3.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.43M $15.86M $24.29M
YoY Change -58.99% -34.72% -21.52%
Accrued Expenses $25.80M $21.70M $23.43M
YoY Change 17.32% -7.38% 15.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $20.00M
YoY Change -100.0% -100.0%
Long-Term Debt Due $5.951M $1.497M
YoY Change
Total Short-Term Liabilities $63.35M $54.63M $79.95M
YoY Change -25.14% -31.67% 28.34%
LONG-TERM LIABILITIES
Long-Term Debt $41.39M $45.38M $0.00
YoY Change
Other Long-Term Liabilities $1.969M $1.905M $2.283M
YoY Change -16.28% -16.56% -4.36%
Total Long-Term Liabilities $43.35M $47.29M $2.283M
YoY Change 1743.28% 1971.35% -4.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $63.35M $54.63M $79.95M
Total Long-Term Liabilities $43.35M $47.29M $2.283M
Total Liabilities $166.1M $160.0M $133.0M
YoY Change 18.57% 20.36% 21.41%
SHAREHOLDERS EQUITY
Retained Earnings -$285.9M -$273.8M -$201.9M
YoY Change 30.81% 35.65% 20.65%
Common Stock $1.000K $1.000K $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.384M $7.471M $25.56M
YoY Change
Total Liabilities & Shareholders Equity $163.7M $167.5M $158.5M
YoY Change 7.32% 5.67% 3.28%

Cashflow Statement

Concept 2017 Q2 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income -$12.09M -$23.31M -$18.80M
YoY Change -27.69% 24.0% 197.39%
Depreciation, Depletion And Amortization $2.300M $2.328M $2.680M
YoY Change -14.81% -13.13% 5.85%
Cash From Operating Activities $200.0K -$24.51M -$15.25M
YoY Change -97.22% 60.74% 32.62%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $3.466M $3.348M
YoY Change -100.0% 3.52% -7.28%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 -$3.466M -$3.348M
YoY Change -100.0% 3.52% -7.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $26.52M $0.00
YoY Change
Debt Paid & Issued, Net $0.00 $55.00K
YoY Change -100.0%
Cash From Financing Activities 100.0K $40.59M $3.046M
YoY Change -101.45% 1232.44% 349.93%
NET CHANGE
Cash From Operating Activities 200.0K -$24.51M -$15.25M
Cash From Investing Activities 0.000 -$3.466M -$3.348M
Cash From Financing Activities 100.0K $40.59M $3.046M
Net Change In Cash 300.0K $12.61M -$15.55M
YoY Change -106.52% -181.08% 7.75%
FREE CASH FLOW
Cash From Operating Activities $200.0K -$24.51M -$15.25M
Capital Expenditures $0.00 $3.466M $3.348M
Free Cash Flow $200.0K -$27.98M -$18.60M
YoY Change -98.25% 50.44% 23.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001463101
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
84276432 shares
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
Enphase Energy, Inc.
CY2016Q1 enph Increase Decreasein Product Warranty Accrual
IncreaseDecreaseinProductWarrantyAccrual
-888000 USD
CY2017Q1 enph Increase Decreasein Product Warranty Accrual
IncreaseDecreaseinProductWarrantyAccrual
580000 USD
CY2016Q1 enph Product Warranty Accrual Accretion Expense
ProductWarrantyAccrualAccretionExpense
384000 USD
CY2017Q1 enph Product Warranty Accrual Accretion Expense
ProductWarrantyAccrualAccretionExpense
495000 USD
CY2016Q4 enph Product Warranty Accrual Current Fair Value Disclosure
ProductWarrantyAccrualCurrentFairValueDisclosure
3296000 USD
CY2017Q1 enph Product Warranty Accrual Current Fair Value Disclosure
ProductWarrantyAccrualCurrentFairValueDisclosure
3467000 USD
CY2016Q4 enph Product Warranty Accrual Noncurrent Fair Value Disclosure
ProductWarrantyAccrualNoncurrentFairValueDisclosure
7036000 USD
CY2017Q1 enph Product Warranty Accrual Noncurrent Fair Value Disclosure
ProductWarrantyAccrualNoncurrentFairValueDisclosure
8160000 USD
CY2017Q1 enph Restructuring And Related Cost Combined Savings
RestructuringAndRelatedCostCombinedSavings
9000000 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
31696000 USD
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
15858000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
61019000 USD
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
48903000 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22937000 USD
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21698000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-292000 USD
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-631000 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
252126000 USD
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
281941000 USD
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2999000 USD
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1929000 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2921000 USD
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2145000 USD
CY2016Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
28000 USD
CY2017Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
945000 USD
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000 USD
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9435000 shares
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9648000 shares
CY2016Q4 us-gaap Assets
Assets
163576000 USD
CY2017Q1 us-gaap Assets
Assets
167507000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
117864000 USD
CY2017Q1 us-gaap Assets Current
AssetsCurrent
122799000 USD
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
84276000 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62269000 shares
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
84276000 shares
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18989000 USD
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23644000 USD
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62269000 shares
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
52361000 USD
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
47703000 USD
CY2016Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
25000000 USD
CY2017Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
50000000 USD
CY2016Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1200000 USD
CY2017Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
3119000 USD
CY2016Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0 USD
CY2017Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
231000 USD
CY2016Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1691000 USD
CY2017Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1309000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28452000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13016000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17764000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29955000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-15436000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12191000 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6411000 USD
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7200000 USD
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
33893000 USD
CY2017Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
34499000 USD
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2680000 USD
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2328000 USD
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
115000 USD
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-418000 USD
CY2017Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
7500000 USD
CY2017Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M24D
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1006000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1145000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
416000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
104000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1665000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1665000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
659000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
520000 USD
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7567000 USD
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5833000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
3664000 USD
CY2017Q1 us-gaap Goodwill
Goodwill
3664000 USD
CY2016Q4 us-gaap Goodwill Gross
GoodwillGross
3664000 USD
CY2017Q1 us-gaap Goodwill Gross
GoodwillGross
3664000 USD
CY2016Q1 us-gaap Gross Profit
GrossProfit
11760000 USD
CY2017Q1 us-gaap Gross Profit
GrossProfit
7048000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18559000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23174000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.41
CY2017Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.30
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
236000 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
131000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2229000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-17458000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1494000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11975000 USD
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4268000 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1395000 USD
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4776000 USD
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1848000 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2062000 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3114000 USD
CY2016Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
286000 USD
CY2017Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
286000 USD
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
945000 USD
CY2017Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
806000 USD
CY2016Q1 us-gaap Interest Expense
InterestExpense
152000 USD
CY2017Q1 us-gaap Interest Expense
InterestExpense
2139000 USD
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
26865000 USD
CY2017Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
30579000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
31960000 USD
CY2017Q1 us-gaap Inventory Net
InventoryNet
33808000 USD
CY2016Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
5095000 USD
CY2017Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
3229000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
162276000 USD
CY2017Q1 us-gaap Liabilities
Liabilities
160036000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
163576000 USD
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
167507000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
82772000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-22095000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9663000 USD
CY2017Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 USD
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
20768000 USD
CY2017Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
45384000 USD
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9333000 USD
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
54629000 USD
CY2016Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
10100000 USD
CY2017Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
23800000 USD
CY2017Q1 us-gaap Long Term Debt
LongTermDebt
46881000 USD
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3032000 USD
CY2017Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1497000 USD
CY2017Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
14687000 USD
CY2017Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
20084000 USD
CY2017Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
15229000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3046000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40586000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3348000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3466000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15249000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24511000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-18795000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-23305000 USD
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
529000 USD
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1079000 USD
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
30848000 USD
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
29143000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-19088000 USD
CY2016Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-194000 USD
CY2017Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-339000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2025000 USD
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1905000 USD
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
681000 USD
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1060000 USD
CY2016Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
55000 USD
CY2017Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3348000 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3466000 USD
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
101000 USD
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7121000 USD
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10133000 USD
CY2016Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
26522000 USD
CY2016Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
24162000 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2000 USD
CY2016Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
10000000 USD
CY2017Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2015Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
30547000 USD
CY2016Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
29659000 USD
CY2016Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
31414000 USD
CY2017Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
31995000 USD
CY2016Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
6651000 USD
CY2016Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
8596000 USD
CY2017Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
8376000 USD
CY2016Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
23008000 USD
CY2016Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
22818000 USD
CY2017Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
23619000 USD
CY2016Q1 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
-419000 USD
CY2017Q1 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
578000 USD
CY2016Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
158000 USD
CY2017Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
291000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31440000 USD
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30905000 USD
CY2016Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
537000 USD
CY2017Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
142000 USD
CY2016Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
7000000 USD
CY2017Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
10100000 USD
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13066000 USD
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9605000 USD
CY2017Q1 us-gaap Restructuring Charges
RestructuringCharges
7200000 USD
CY2016Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
25000 USD
CY2017Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
1920000 USD
CY2016Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 USD
CY2017Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
7247000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-250535000 USD
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-273840000 USD
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
64121000 USD
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
54751000 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.29
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.42
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10215000 USD
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6458000 USD
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2999000 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1929000 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
812000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
6.50
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
191000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1300000 USD
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8730000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8103000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.56
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.15
CY2016Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1719000 USD
CY2017Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1617000 USD
CY2016Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
708000 USD
CY2017Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
834000 USD
CY2017Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6000 shares
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
1300000 USD
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
7471000 USD
CY2016Q1 us-gaap Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
0 USD
CY2017Q1 us-gaap Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
1400000 USD
CY2017Q1 us-gaap Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
1447000 USD
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46209000 shares
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
76651000 shares
CY2017Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Significant estimates and assumptions reflected in the financial statements include revenue recognition, inventory valuation and accrued warranty obligations. These estimates are based on information available as of the date of the financial statements; therefore, actual results could differ materially from management&#8217;s estimates using different assumptions or under different conditions.</font></div></div>

Files In Submission

Name View Source Status
0001463101-17-000054-index-headers.html Edgar Link pending
0001463101-17-000054-index.html Edgar Link pending
0001463101-17-000054.txt Edgar Link pending
0001463101-17-000054-xbrl.zip Edgar Link pending
a2017q110-qexx311.htm Edgar Link pending
a2017q110-qexx312.htm Edgar Link pending
a2017q110-qexx321.htm Edgar Link pending
a2017q1form10-q.htm Edgar Link pending
enph-20170331.xml Edgar Link completed
enph-20170331.xsd Edgar Link pending
enph-20170331_cal.xml Edgar Link unprocessable
enph-20170331_def.xml Edgar Link unprocessable
enph-20170331_lab.xml Edgar Link unprocessable
enph-20170331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending